Related Experiment Video
Updated: Jun 11, 2026

07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Pancreatic cancer stem cells - update and future perspectives
Enza Lonardo1, Patrick C Hermann, Christopher Heeschen
1Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), C/ Melchor Fernandez Almagro 3, Madrid, Spain.
Molecular Oncology
|June 29, 2010
Summary
Cancer stem cells drive solid tumor growth and resistance. Targeting these cells, particularly in pancreatic cancer, offers a promising therapeutic strategy for improved treatment outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Stem Cell Research
Background:
- Solid tumors exhibit heterogeneity, suggesting a hierarchical organization.
- The cancer stem cell (CSC) hypothesis posits that a distinct cell subpopulation drives tumor growth, metastasis, and therapeutic resistance.
Purpose of the Study:
- To review recent advances in cancer stem cell research.
- To focus on CSCs in pancreatic cancer, a highly lethal malignancy.
- To highlight challenges and future directions in the field.
Main Methods:
- Review of current scientific literature on cancer stem cells.
- Emphasis on evidence from mouse models for CSC identification in pancreatic cancer.
- Analysis of therapeutic strategies targeting CSCs.
Main Results:
- Increasing evidence supports hierarchical organization in solid tumors, including pancreatic cancer, sustained by CSCs.
- Direct evidence in human pancreatic cancer remains debated due to model limitations, but mouse models provide supportive data.
- Specific elimination of CSCs is suggested to be therapeutically relevant.
Conclusions:
- Targeting signaling pathways crucial for CSC maintenance and elimination may lead to novel pancreatic cancer treatments.
- Despite ongoing challenges, CSCs represent a critical target for improving pancreatic cancer therapy.
- Further research is needed to fully elucidate the role and therapeutic targeting of CSCs in human pancreatic cancer.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...

